Log in

OTCMKTS:ASNBAdvanSource Biomaterials Corpration Stock Price, Forecast & News

$0.03
+0.01 (+20.00 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.02
MA: $0.09
$0.20
52-Week Range
$0.02
Now: $0.03
$0.23
Volume29,200 shs
Average Volume134,167 shs
Market Capitalization$644,700.00
P/E Ratio2.50
Dividend YieldN/A
Beta-0.59
AdvanSource Biomaterials Corp. engages in the development of polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. Its products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.75 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ASNB
CUSIPN/A
Phone424-256-8560

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.35 million
Cash Flow$0.02 per share
Book Value($0.01) per share

Profitability

Net Income$330,000.00

Miscellaneous

Employees11
Market Cap$644,700.00
Next Earnings Date8/27/2020 (Estimated)
OptionableNot Optionable

Receive ASNB News and Ratings via Email

Sign-up to receive the latest news and ratings for ASNB and its competitors with MarketBeat's FREE daily newsletter.

AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) Frequently Asked Questions

How has AdvanSource Biomaterials Corpration's stock been impacted by COVID-19 (Coronavirus)?

AdvanSource Biomaterials Corpration's stock was trading at $0.1470 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ASNB shares have decreased by 79.6% and is now trading at $0.03. View which stocks have been most impacted by Coronavirus.

When is AdvanSource Biomaterials Corpration's next earnings date?

AdvanSource Biomaterials Corpration is scheduled to release its next quarterly earnings announcement on Thursday, August 27th 2020. View our earnings forecast for AdvanSource Biomaterials Corpration.

How were AdvanSource Biomaterials Corpration's earnings last quarter?

AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) announced its earnings results on Thursday, October, 16th. The company reported $0.31 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.02. During the same quarter in the prior year, the business earned $0.27 earnings per share. View AdvanSource Biomaterials Corpration's earnings history.

Has AdvanSource Biomaterials Corpration been receiving favorable news coverage?

Headlines about ASNB stock have been trending extremely negative on Wednesday, InfoTrie reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. AdvanSource Biomaterials Corpration earned a daily sentiment score of -4.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutAdvanSource Biomaterials Corpration.

Who are some of AdvanSource Biomaterials Corpration's key competitors?

What other stocks do shareholders of AdvanSource Biomaterials Corpration own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AdvanSource Biomaterials Corpration investors own include Associated Banc (ASB), PermRock Royalty Trust (PRT), CytoDyn (CYDY), FuelCell Energy (FCEL), Interpace Diagnostics Group (IDXG), Sphere 3D (ANY), Champions Oncology (CSBR), CannTrust (CTST), Curaleaf (CURLF) and ITT Educational Services (ESINQ).

Who are AdvanSource Biomaterials Corpration's key executives?

AdvanSource Biomaterials Corpration's management team includes the following people:
  • Michael F. Adams, President & Chief Executive Officer
  • Khristine L. Carroll, Senior Vice President-Commercial Operations

What is AdvanSource Biomaterials Corpration's stock symbol?

AdvanSource Biomaterials Corpration trades on the OTCMKTS under the ticker symbol "ASNB."

How do I buy shares of AdvanSource Biomaterials Corpration?

Shares of ASNB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AdvanSource Biomaterials Corpration's stock price today?

One share of ASNB stock can currently be purchased for approximately $0.03.

How big of a company is AdvanSource Biomaterials Corpration?

AdvanSource Biomaterials Corpration has a market capitalization of $644,700.00 and generates $3.35 million in revenue each year. AdvanSource Biomaterials Corpration employs 11 workers across the globe.

What is AdvanSource Biomaterials Corpration's official website?

The official website for AdvanSource Biomaterials Corpration is www.advbiomaterials.com.

How can I contact AdvanSource Biomaterials Corpration?

AdvanSource Biomaterials Corpration's mailing address is 229 ANDOVER STREET, WILMINGTON MA, 01887. The company can be reached via phone at 424-256-8560 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.